Clinical Trials/Research Study Participation Opportunities

Children and Adolescents -

Omega 3 Fatty Acids in the Treatment of Children with Autism Spectrum Disorders - The Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School (RWJMS), is currently recruiting child volunteers aged 5 - 17 for a 12-week clinical study examining the impact of Omega 3 Fatty Acids on irritability associated with autism. To be eligible, participants must have a diagnosis of autism. Participants diagnosed with Mood Disorder NOS may also be eligible. Interview and questionnaire completion will comprise 2-3 visits, each ranging from 1-3 hours. Those who qualify will be closely monitored by the study doctor. Dietary supplements will be provided at no cost. Sherie Novotny, MD, is the Principal Investigator. For more information, please call Annie Kutlik, Clinical Research Coordinator, at 732-235-5690.

Oxcarbazepine versus Placebo in Childhood Autism - The Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School (RWJMS), is currently recruiting child volunteers aged 5 - 17 for a 12-week clinical drug study examining the impact of Oxcarbazepine on mood instability and irritability associated with autism. To be eligible, participants must have a diagnosis of autism and must be willing to undergo an interview. The interview and questionnaires may take up to four hours to complete. The interview may be completed at a second visit if necessary. Those who qualify will be closely monitored by the study doctor. Medication will be provided at no cost. Sherie Novotny, MD, is the Principal Investigator. For more information, please call Annie Kutlik, Clinical Research Coordinator, at 732-235-5690.

Aripiprazole versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children - The Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School (RWJMS), is currently recruiting child volunteers aged 5 - 17 for an 8-week clinical drug study examining the impact of Aripiprazole on aggressive and aberrant behavior associated with autism. To be eligible, participants must have a diagnosis of autism and must be willing to undergo an interview. The interview and questionnaires may take up to four hours to complete. The interview may be completed at a second visit if necessary. Those who qualify will be closely monitored by the study doctor. Medication will be provided at no cost. Sherie Novotny, MD, is the Principal Investigator. For more information, please call Annie Kutlik, Clinical Research Coordinator, at 732-235-5690.

An Open-Label, Prospective, Cohort Study of Antidepressants in Children and Adolescents with Anxiety Disorders, Depressive Disorders, Eating Disorders, or Obsessive-Compulsive Disorder - The Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School (RWJMS), is currently recruiting child volunteers aged 7 - 17, with anxiety disorders, depressive disorders, eating disorders, or obsessive-compulsive disorder, to participate in a study of the safety, tolerability, and effectiveness of SSRI and SNRI antidepressants for children and adolescents with anxiety disorders, depressive disorders, eating disorders, or obsessive-compulsive disorder. This information will help clinicians better understand the balance of risk and benefit associated with these classes of medication. The study will have two phases, an acute treatment phase following initiation of treatment with any SSRI or SNRI of the clinician’s choosing and a long-term follow up. The acute treatment phase will last twelve (12) weeks and the long-term follow up will occur six (6) and nine (9) months after initiation of treatment. Children in this study must be under the care of a child and adolescent psychiatrist and must be receiving current, stable drug treatment for their behavioral or emotional problem. Theodore A. Petti, MD, is the Principal Investigator. For more information, please call Annie Kutlik, Clinical Research Coordinator, at 732-235-5690.

Adults -

Do you have widespread pain or fibromyalgia? Researchers at the Department of Psychiatry, Robert Wood Johnson Medical School, are conducting a research study using Lunesta, an FDA-approved drug for insomnia, to treat the symptoms of fibromyalgia. You may qualify if you are between the ages of 18 to 64, you have fibromyalgia, and you are having difficulty sleeping. Participants will receive $20 per visit. For more information, please call Lesley Allen, Ph.D., Principal Investigator, Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, at 732-235-4412 or 732-235-3378.

Are you bothered by multiple, persistent physical symptoms (such as pain, fatigue, gastrointestinal difficulties or menstrual difficulties)? Do you have fibromyalgia, irritable bowel syndrome, chronic fatigue syndrome, TMJ, or chemical sensitivities? You may be eligible for a free treatment study. Dr. Lesley Allen is studying a new psychosocial treatment designed to help reduce physical discomfort. Participants must be 18-65 years of age and have multiple unexplained physical symptoms. For more information, call Lesley Allen, PhD, Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, at 732-235-4412.

Dr. Paul Lehrer, of the Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, is currently recruiting individuals aged 18 - 70 who have multiple, unexplained physical symptoms to participate in a study of the efficacy of a new biofeedback treatment. Participants who, after screening, are determined to be eligible for the study will be randomly assigned to either a “treatment” group or a “waiting list control” group. The treatment will comprise 10 weekly training sessions (approximately 1 hour each) in muscle relaxation, a structured method of self-hypnosis (autogenic training), and biofeedback (using physiological monitoring equipment as a method to train people to control their heart rate variability, breathing, and muscle tension). Participants will be paid $25 each for the three evaluation sessions. If interested, please call Maria Karavidas, PsyD, at 732-235-4628 or e-mail karavima@umdnj.edu.

Have asthma? Often feel stressed or anxious? Do you have one or more of these symptoms? Racing heart, sweating, chest pain, choking, lightheadedness, dizziness, nausea, tingling, chills, shaking, feelings of unreality, a need to escape. All these can be symptoms of panic. Researchers at the Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, are testing a non-drug treatment for people who have both asthma and panic. Treatment is free. Volunteers are paid $25 for each of four testing sessions. For more information please call Paul Lehrer, PhD, at 732-235-4413 or e-mail lehrer@umdnj.edu.

Do you feel sad, irritable, tired, and uninterested? Do you have concentration, appetite, and sleep problems? You may be suffering from depression. Dr. Paul Lehrer, of the Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, is conducting a research study using a new, non-drug technique to treat depression. Treatment does not involve medication. Participants must be between the ages of 18 and 75 and medically stable. This investigational treatment is provided at no cost. For more information, please call Maria Karavidas, PsyD, at 732-235-4628 or karavima@umdnj.edu.